Vycor Medical (VYCO) Payables (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Payables data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Payables rose 7.89% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 7.89% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 8.62% from the prior year.
• Payables for Q1 2026 stood at $3.5 million, up from $3.3 million in the prior quarter.
• Over the last five years, Payables for VYCO reached as high as $3.5 million in Q1 2026 and fell as low as $426773.0 in Q2 2023.
• Historically, Payables has averaged $2.0 million across 5 years, with a median of $2.9 million in 2024.
• Across the five-year window, Payables declined 22.18% in 2023 and jumped 581.33% in 2024, its largest moves.
• Year by year, Payables stood at $524755.0 in 2022, then surged by 417.7% to $2.7 million in 2023, then climbed by 12.89% to $3.1 million in 2024, then increased by 8.62% to $3.3 million in 2025, then gained by 4.62% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.5 million in Q1 2026, $3.3 million in Q4 2025, and $3.4 million in Q3 2025.